title: Authors' reply to Turner and colleagues.
authors.affiliation: Centre for Infectious Disease Epidemiology and MRC Clinical Trials Unit, University College London, London, UK i.abubakar@ucl.ac.uk.
authors.forename: I
authors.initials: I
authors.lastname: Abubakar
authors.affiliation: Tuberculosis Research Centre, Respiratory Infections Section, National Heart and Lung Institute, Imperial College London, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Sridhar
authors.affiliation: Luton and Dunstable University Hospital, NHS Foundation Trust, Luton, UK.
authors.forename: M
authors.initials: M
authors.lastname: Eisenhut
authors.affiliation: Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Roy
authors.affiliation: Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK.
authors.forename: R J
authors.initials: RJ
authors.lastname: Harris
authors.affiliation: London School of Hygiene and Tropical Medicine, London, UK.
authors.forename: L C
authors.initials: LC
authors.lastname: Rodrigues
authors.affiliation: London School of Hygiene and Tropical Medicine, London, UK.
authors.forename: P
authors.initials: P
authors.lastname: Mangtani
authors.affiliation: Medical Research Council, Fajara, Gambia.
authors.forename: I
authors.initials: I
authors.lastname: Adetifa
authors.affiliation: Tuberculosis Research Centre, Respiratory Infections Section, National Heart and Lung Institute, Imperial College London, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Lalvani
mesh_terms: D001500:BCG Vaccine; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D014376:Tuberculosis / Q000517:prevention & control*
chemical_list: D001500:BCG Vaccine